CurrentUnitedHealthcarePolicy DCPO28.12

Oral Surgery: Alveoloplasty and Vestibuloplasty

Clinical policy governing coverage considerations for alveoloplasty and vestibuloplasty procedures for UnitedHealthcare dental plans; intended for dental providers making coverage decisions for members.

Policy Summary

PayerUnitedHealthcare

PolicyOral Surgery: Alveoloplasty and Vestibuloplasty

Policy CodePolicy DCPO28.12

Change TypeMaterial update — added exclusion for prior head/neck radiation

Effective DateOct 1, 2025

Next Review Date

Key ActionVerify member benefits and obtain any required prior authorization per the member's dental plan.

SourceLink

POLICY UPDATE CHANGES

Added language stating Alveoloplasty may not be indicated for individuals who have undergone radiation therapy to the head and neck.

7named CDT procedure codes listed

2procedures covered

1state-specific mandate referenced

1archived prior version referenced

Coverage Criteria — Alveoloplasty and Vestibuloplasty

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Covered Indications

Covered when ONE of the following clinical indications applies:

Alveoloplasty indications: Alveoloplasty is indicated when performed as a standalone procedure prior to fixed or removable prosthetic construction; for debulking pathologic bone conditions; or to provide stability for implant placement.

Refer to CDT codes D7310-D7321 for coding.

Vestibuloplasty indications: Vestibuloplasty is indicated to complement and complete osseous reconstruction of edentulous bone, to provide overall stability of a dental implant and maintenance of peri-implant bone health, or to correct inadequate soft tissue drape when prosthetic restoration requires improvement.

Refer to CDT codes D7340-D7350 for coding.

Not Indicated / When Procedure May Not Be Appropriate

Not indicated (coverage exclusion considerations) when ANY of the following apply:

Anatomic or surgical contraindications: Diminished volume or atypical bone architecture where the procedure is inappropriate; minimal alveolar ridge height (for vestibuloplasty); or when removing bone would harm vital structures.

These anatomic situations may render the procedure not indicated.

Prior radiation therapy: Individuals who have undergone radiation therapy to the head and neck.

Prior head and neck radiation may impair healing and contraindicate alveoloplasty/vestibuloplasty.

Medications impairing healing: Individuals taking medications that negatively affect the healing response, including but not limited to immunosuppressive agents, corticosteroids, anticoagulants, NSAIDs, and nicotine.

Medication-related impaired healing may render the procedure not indicated.

Unmanaged medical conditions: Individuals with unmanaged medical conditions that affect healing, including but not limited to metabolic, cardiovascular, autoimmune/inflammatory disorders, or genetic conditions affecting collagen synthesis.

Uncontrolled systemic illness may contraindicate the procedure.

Procedures may be not indicated when patient-specific anatomic or physiologic factors increase the risk of harm or reduce the likelihood of benefit. Contraindications include diminished alveolar volume or atypical bone architecture where recontouring is inappropriate, and situations where removal of bone would risk injury to vital structures. Prior head and neck radiation is specifically listed as a contraindication. Additionally, individuals taking medications that impair healing — including but not limited to immunosuppressive agents, corticosteroids, anticoagulants, NSAIDs, and nicotine — or those with unmanaged medical conditions (for example metabolic, cardiovascular, autoimmune/inflammatory disorders, or genetic collagen disorders) may not be appropriate candidates for alveoloplasty or vestibuloplasty.

For vestibuloplasty specifically, absence of sufficient alveolar ridge height is a contraindication: the procedure is not indicated when there is minimal alveolar ridge height. These clinical contraindications may render the procedure not indicated because they increase the risk of impaired healing or compromise prosthetic or implant outcomes.

Use of alveoloplasty or vestibuloplasty is considered not medically necessary when listed contraindications exist such that the procedure would not improve prosthetic or implant outcomes or would introduce undue risk (for example, prior head and neck radiation, medications that impair healing, unmanaged systemic conditions, minimal ridge height for vestibuloplasty, or when bone removal would endanger vital structures).

When evaluating medical necessity, document and consider whether conservative or alternative management could achieve the same functional goals without surgery. If the clinical record shows one or more of the contraindications above, coverage is unlikely and prior authorization should reflect the clinical rationale for denial when applicable.

Procedure Codes and Coding Guidance

Referenced CDT Procedure CodesCDT/mixed

D7310	Alveoloplasty in conjunction with extractions four or more teeth or tooth spaces, per quadrant.
D7311	Alveoloplasty in conjunction with extractions one to three teeth or tooth spaces, per quadrant.
D7320	Alveoloplasty not in conjunction with extractions four or more teeth or tooth spaces, per quadrant.
D7321	Alveoloplasty not in conjunction with extractions one to three teeth or tooth spaces, per quadrant.
D7340	Vestibuloplasty ridge extension (secondary epithelialization).
D7350	Vestibuloplasty ridge extension (including soft tissue grafts, muscle reattachment; revision of soft tissue attachment and management of hypertrophied and hyperplastic tissue).

Provider Actions and Administrative Requirements

Prior Authorization

Prior Authorization and Benefit Verification

Verify the member-specific benefit plan document and obtain any required prior authorization before scheduling services.

Check the member's plan for dental coverage limitations and eligibility.
Obtain prior authorization when the member's plan requires it; failure to obtain prior authorization may result in claim denial.

Note

Provider Action Highlights

Confirm and document any supplemental provider-facing actions required by the member's plan (e.g., referral, pre-treatment estimate) before performing procedures.

Obtain referrals if required by the member's plan.
Submit pre-treatment estimates when requested by the plan or when extensive surgical work is planned.

Documentation Required

Required Clinical Documentation

Document the clinical indication, anatomic findings, and treatment planning in the patient record. Include operative notes, radiographs, and rationale for the selected procedure.

Record clinical indication (e.g., sharp alveolar bone, preparation for prosthesis or implant).
Include pre- and post-operative radiographs and intraoperative findings.
Provide a documented treatment plan showing why alveoloplasty or vestibuloplasty is necessary versus alternative therapies.

Denial Risk

Clinical Situations Increasing Denial Risk

Certain clinical situations increase the risk of denial or noncoverage. Review and document these factors carefully.

Procedures for members with diminished bone volume or atypical bone architecture may be not indicated.
Cases where removing bone could harm vital structures may be noncovered.
Members who have received head and neck radiation therapy may be excluded from coverage for these procedures.
Use of medications that impair healing (immunosuppressants, corticosteroids, anticoagulants, NSAIDs, nicotine) should be documented; such factors may lead to denial.
Unmanaged medical conditions (metabolic, cardiovascular, autoimmune/inflammatory, genetic collagen disorders) increase denial risk.
Minimal alveolar ridge height that precludes benefit from vestibuloplasty should be documented as a denial risk.

Background and Rationale

Alveoloplasty is a surgical procedure to recontour and smooth the alveolar bone, commonly performed after tooth extractions or in preparation for fixed or removable prosthetic or implant placement to create an optimal osseous foundation. Vestibuloplasty comprises procedures to lower or reposition mucosal and muscle attachments to increase relative alveolar ridge height and improve soft tissue drape and prosthetic fit.

These procedures are intended to facilitate prosthetic stability, implant support, and appropriate soft tissue contours. Nonpharmacologic pain management strategies are encouraged where applicable and clinical decision-making should account for patient systemic health, medication use, and anatomic suitability prior to proceeding.

Definitions

Alveoloplasty — Definition and short descriptor.

TermAlveoloplasty

DefinitionSurgical procedure for recontouring supporting bone, sometimes in preparation for a prosthesis. (ADA)

Typical indicationsPerformed to recontour/smooth alveolar bone after extractions or prior to fixed or removable prosthetic construction or implant placement.

Vestibuloplasty — Definition and short descriptor.

TermVestibuloplasty

DefinitionA series of surgical procedures designed to increase relative alveolar ridge height. (ADA)

Typical indicationsUsed to increase vestibular depth or lower/reposition mucosal and muscle attachments to improve prosthetic fit and soft tissue drape.